Projections for oesophageal cancer incidence in England to 2033

European Journal of Cancer Prevention

Volumn 20, Issue 4, 2011, Pages 283-286

  Gatenby, Piers Anthony Cheyne ^a   Hainsworth, Alison ^b   Caygill, Christine ^a   Watson, Anthony ^a   Winslet, Marc ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

England; epidemiology; forecasting; oesophageal neoplasms; population

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; DEMOGRAPHY; ESOPHAGUS CANCER; FEMALE; HUMAN; LIFE EXPECTANCY; MALE; MIGRATION; PRIORITY JOURNAL; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; ESOPHAGEAL NEOPLASMS; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; SURVIVAL RATE;

EID: 79958810382     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32834572d2     Document Type: Article

References (14)

1. Abdel-Rahman M, Stockton D, Rachet B, Hakulinen T, Coleman MP (2009). What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer 101:S115-S124.
2. Corley DA, Kerlikowske K, Verma R, Buffler P (2003). Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and metaanalysis. Gastroenterology 124:47-56. (Pubitemid 36055338)
3. Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow W-H, et al. (1997). Tobacco, alcohol and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 89:1277-1284. (Pubitemid 27371948)
4. Ganz RA, Overholt BF, Sharma VK, Fleischer DE, Shaheen NJ, Lightdale CJ, et al. (2008). Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a US Multicenter Registry. Gastrointest Endosc 68:35-40. (Pubitemid 351902211)
5. Gatenby PAC, Caygill CPJ, Ramus JR, Charlett A, Watson A (2008). Barrett's columnar-lined oesophagus: demographic associations and adenocarcinoma risk. Dig Dis Sci 53:1175-1185. (Pubitemid 351514632)
6. Gatenby PA, Ramus JR, Caygill CP, Winslet MC, Watson A (2009). Aspirin is not chemoprotective for Barrett's adenocarcinoma of the oesophagus in multicentre cohort. Eur J Cancer Prev 18:381-384.
7. International Agency for Research on Cancer (2007). Cancer incidence in five continents. Volume IX. Curado MP, Edwards B, Shin HR, et al., editors. Lyon, France: Scientific Publications; pp. 680-687.
8. Lagergren J, Bergstrom R, Lindgren A, Nyren O (1999). Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825-831. (Pubitemid 29142625)
9. Lepage C, Rachet B, Jooste V, Faivre J, Coleman MP (2008). Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol 103:2694-2699.
10. Mayne ST, Risch HA, Dubrow R, Chow WH, Gammon MD, Vaughan TL, et al. (2001). Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 10:1055-1062. (Pubitemid 32959152)
11. National Centre for Health Outcomes Development (2009). Incidence of Oesophageal Cancer (ICD10 C15). 06-V1. http://www.nchod.nhs.uk. (Accessed 1 March 2010)
12. Office for National Statistics (2010). Cancer survival in England: one-year and five-year survival for 21 common cancers, by sex and age. http://www.statistics.gov.uk/statbase/product.asp?vlnk=884&pos= 3&colrank=2&rank=272. (Accessed 1 March 2010)
13. Olsen AH, Parkin DM, Sasieni P (2008). Cancer mortality in the United Kingdom: projections to the year 2025. Br J Cancer 99:1549-1554.
14. Population Estimates Unit (2010). Mid-Year Population Estimates. ISBN 0116909714. Newport, South Wales. http://www.statistics.gov.uk/statbase/product. asp?vlnk=15106. (Accessed 1 March 2010)